Arun Goel

Arun Goel, MD

Assistant Professor of Clinical Radiation Oncology

Department: Radiation Oncology

Contact information

3400 Civic Center Blvd.
Perelman Center for Advanced Medicine
Philadelphia, PA 19104

Education:
BA (Biology Modified with Chemistry)
Dartmouth College, 2009.
MD (Doctorate of Medicine)
Drexel University College of Medicine, 2014.

Permanent link

> Perelman School of Medicine > Faculty > Details

Description of Clinical Expertise

HDR Brachytherapy
HDR Prostate Brachytherapy
HDR Gynecologic Brachytherapy
Prostate SBRT
Ultrasound-based HDR Brachytherapy

Selected Publications

Hsu M, Shan X, Zhang R, Berlin E, Goel A, Agarwal M, Wong YN, Christodouleas JP, Vaughn DJ, Narayan V, Takvorian SU, Vapiwala N, Pantel AR, Haas NB: Prostate Cancer Recurrence: Examining the Role of Salvage Radiotherapy Field and Risk Factors for Regional Disease Recurrence Captured on 18F-DCFPyL PET/CT. Clin Genitourin Cancer 22(4): 102108, Aug 2024.

Shah NK, Kim KN, Grewal A, Wang X, Ben-Josef E, Plastaras JP, Metz JM, Goel A, Taunk NK, Shabason JE, Lukens JN, Berman AT, Wojcieszynski AP: Activity Monitoring for Toxicity Detection and Management in Patients Undergoing Chemoradiation for Gastrointestinal Malignancies. JCO Oncology Practice 18(6): e896-e906, Jun 2022.

Manuj Agarwal MD, Christopher Wright MD, Shweta Manjunath MD, Arun Goel MD: Dose Escalation for High-Risk Prostate Cancer: Brachytherapy versus Stereotactic Body Radiotherapy Boost. ABS BrachyBlast NewsLetter Feb 2022.

Gorovets D, Hopkins M, Kollmeier M, Moore A, Goel A, Shasha D, Brennan V, McBride S, Cohen G, Damato AL, Zelefsky MJ: Early outcomes of high-dose-rate brachytherapy combined with ultra-hypofractionated radiation in higher-risk prostate cancer. Brachytherapy 20(6): 1099-1106, Nov-Dec 2021.

Arun Goel MD, Chi-Mei Liu Ph.D, Praneet Kaur, Michael L. Wong MD, Lawrence M. Scala MD: Genitourinary Toxicity in patients with Intermediate and High Risk Prostate Cancer managed with Hypofractionated Radiation and HDR Brachytherapy Boost. American Society for Radiation Oncology Annual Meeting, San Antonio, TX 2018 Notes: e-poster

Huang AJ, Huang KE, Kumar RJ, Goel A, Harandi NK, Birer SR, Rounsaville MC, Lee JW, Abendroth R: Two-Fraction Radiosurgery (9Gy x 2) is an effective and safe option in the Modern Era of CNS-Penetrating Systemic Therapies Radiological Society of North America Annual Meeting, Chicago, IL 2018 Notes: oral.

Huang AJ, Huang KE, Kumar RJ, Goel A, Harandi NK, Rounsaville MC, Abendroth RE, Lee JW: Dose-Reduced Stereotactic Radiosurgery for Brain Metastases in the Era of CNS-Penetrating Systemic Therapies American Society for Radiation Oncology Annual Meeting, San Antonio, TX 2018 Notes: poster.

Harandi NK, Goel A, Huang AJ, Huang KE, Abendroth RA, Lee JW, Kashani-Sabet M, Kim KB: Outcomes for advanced melanoma with brain metastases treated with stereotactic radiosurgery (SRS) with and without PDL1 therapy American Society for Radiation Oncology Annual Meeting, San Antonio, TX 2018 Notes: poster.

Goel A, Kumar RJ, Linam JM, Huang AJ, Abendroth RE, Lee JW, Andrews B, Leong S, Leng LZ, Minor D, Nosrati M, Vosoughi E, Miller J, Kashani-Sabet M, Kim K: Impact of Anti-PD-1 Treatment in Patients with Metastatic Melanoma Brain Lesions Treated with Stereotactic Radiosurgery. International Journal of Radiation Oncology *Biology * Physics. 2017 Oct; 99(2S): S2177 American Society for Radiation Oncology Annual Meeting, San Diego, CA 2017 Notes: poster.

Huang AJ, Huang KE, Goel A, Kumar RJ, Linam JL, Lee JW: Advances in Healthcare Accessibility and Imaging Technology Have Led to Shifts in the Proportion of Early and Late Stage Pediatric Cancers: An Analysis of the 1994-2013 SEER Registries International Journal of Radiation Oncology * Biology * Physics 2017 Oct; 99(2S):S2949. American Society for Radiation Oncology Annual Meeting, San Diego, CA 2017 Notes: poster.